¹ú±êÂ鶹ÊÓƵAPP

¹ú±êÂ鶹ÊÓƵAPP Petr Vaclav explains how behavioral and contextual signals can improve the life insurance value chain. Curious about ¹ú±êÂ鶹ÊÓƵAPP data insights?  

Read More

Curious about ¹ú±êÂ鶹ÊÓƵAPP medical insights?   Conta...

Read More

Alternative data sources and supporting technologies are propelling today’s advances in underwriting, enabling acceleration. Accelerated underwriting is empowering insurers to speed processes and improve the customer experience. 

Read More

In this Inside RGA Q&A, Sandi Hubert, Senior Vice President, Chief Operating Officer at , discusses the importance of innovation in life and health insurance, what the team is currently... Read More

Much of the available data regarding the therapeutic use of psychedelics for mental health disorders remains introductory; however, momentum is building with the potential to offer unique treatments for many complex mental health disorders.

Read More

New pharmaceuticals to treat sickle cell disease (SCD) are steadily improving the health and wellbeing of many people living with this chronic disorder. It is hoped that revolutionary gene therapies now in clinical trials will be able to cure more SCD patients. The r...

Read More

GPT-4 features stronger safety and privacy guardrails, longer input and output text, and more accurate, detailed, and concise responses for nuanced questions. Although it offers exciting opportunities for insurance and countless other industries, its potential provid...

Read More

Many health insurers exclude experimental treatments without clearly defining which treatments they would consider experimental. In this Global Health Brief, ¹ú±êÂ鶹ÊÓƵAPP Colin Weston discusses the need for clear definitions in policy language. He also explores how drugs, t...

Read More

In a Society of Actuaries , ¹ú±êÂ鶹ÊÓƵAPP Ryan Holt discusses the confusion matrix and how actuaries have leveraged it in the accelerated underwriting (AU) space.&n... Read More

Asset-intensive reinsurance is growing in popularity in the life insurance industry, and it is more important than ever for insurers to seek out trusted partners when selecting an asset-intensive reinsurer.

Read More

Digital health is here to stay and will continue to grow. Enabling virtual access to healthcare can empower policyholders to actively manage and improve their own health and wellness, while equipping insurers to optimize portfolio management and performance.
Read More

Explore RGActual, our magazine covering innovation, experience, and development for insurance professionals. In this issue, we continue our celebration of 50 years of positive impact. 

Read More

Although much of the spotlight is currently on ChatGPT, the generative artificial intelligence (AI) landscape is much broader. In this article, ¹ú±êÂ鶹ÊÓƵAPP Neil Parkin provides an overview of potential opportunities emerging from AI for insurers.

Read More

The Geneva Association recently published a comprehensive report on the ongoing mental health crisis and the insurance industry’s role and responsibility in promoting mental wellbeing to help address this growing societal challenge.

Read More

Learn more about the latest trends and developments in life and health insurance by exploring findings from RGA’s 2022 surveys.  Read More

In this Inside RGA Q&A, Adela Osman, Head of Global Medical, explains why she chose a career in the life and health insurance industry, what RGA Magic means, and how she plans to build on the successful legacy of RGA’s medical team.
Read More

As the need for mental health services and associated insurance coverage increases, the quest for solutions becomes more urgent. Psychedelics may be part of the solution.
Read More

RGA provides quarterly updates on global product developments, which can be made available upon request.

Read More

People are talking about ChatGPT, the AI-powered chatbot capable of processing mountains of text data, providing detailed responses to questions, and engaging in conversation like a human. We decided to put ChatGPT to the test and to consider the implications this tool ... Read More

The great promise of gene therapy must be weighed against the challenges of high short-term costs. Effective case management and expanded education efforts will be essential to progress.


Read More